Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1979-8-16
pubmed:abstractText
Compared to littermate controls (C57BL/6J ob/?), body weights of genetically obese (ob/ob) mice are significantly higher at 1-6 months of age; the greatest percentage weight gain of the ob/ob group occurs during the first 3 months of life. Levels of pituitary immunoreactive beta-endorphin and immunoreactive alpha-melanocyte-stimulating hormone are also significantly elevated in ob/ob animals compared to controls. However, these pharmacological differences only emerge at 4-6 months of age--3 months after the appearance of obesity. High levels of immunoreactive endorphin in the pituitary are, therefore, more likely to be a consequence than a cause of obesity. Furthermore, numerous other neurologic abnormalities, which may or may not play a role in the obesity syndrome, are evident in ob/ob mice. Compared to controls, ob/ob total brain, hypothalamus, and pituitary weights are 11%, 16%, and 23% less, respectively. Levels of immunoreactive Leu5-enkephalin in pars nervous are also 200% higher in ob/ob mice; this increase is apparent at 1-6 months of age and is highly correlated with changes in body weight.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-1008843, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-14824537, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-167093, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-167751, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-169296, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-170108, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-174889, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-197529, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-197601, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-201864, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-202948, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-24182, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-270754, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-277953, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-340309, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-417760, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-4352887, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-4588246, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-4823299, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-5162297, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-5950056, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-715455, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-758680, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-883982, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-890498, http://linkedlifedata.com/resource/pubmed/commentcorrection/287046-917261
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2077-80
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1979
pubmed:articleTitle
Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development.
pubmed:publicationType
Journal Article